The Beauty Health Company (SKIN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Beauty Health (SKIN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Fast-paced Mover Beauty Health (SKIN) Is a Great Choice for Value Investors
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Beauty Health (SKIN) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Despite Fast-paced Momentum, Beauty Health (SKIN) Is Still a Bargain Stock
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Beauty Health (SKIN) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Beauty Health (SKIN) Reliance on International Sales: What Investors Need to Know
Explore Beauty Health's (SKIN) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
The Beauty Health Company (SKIN) Q1 2025 Earnings Conference Call Transcript
The Beauty Health Company (NASDAQ:SKIN ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Norberto Aja - IR Marla Beck - President and CEO Mike Monahan - CFO Conference Call Participants Susan Anderson - Canaccord Genuity Jon Block - Stifel Olivia Tong - Raymond James Bruce Jackson - Benchmark Company Navann Ty - BNP Paribas Operator Good day, everyone, and welcome to today's Beauty Health Company First Quarter 2025 Earnings Call. At this time all participants are in a listen-only mode.
Beauty Health (SKIN) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Beauty Health (SKIN) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
The Beauty Health Company (SKIN) Reports Q1 Loss, Tops Revenue Estimates
The Beauty Health Company (SKIN) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.10 per share a year ago.
The Beauty Health Company (SKIN) Q4 2024 Earnings Call Transcript
The Beauty Health Company (NASDAQ:SKIN ) Q4 2024 Earnings Conference Call March 12, 2025 4:30 PM ET Company Participants Norberto Aja - Investor Relations Marla Beck - President and Chief Executive Officer Mike Monahan - Chief Financial Officer Conference Call Participants Susan Anderson - Canaccord Genuity Oliver Chen - TD Cowen Olivia Tong - Raymond James Ashley Helgans - Jefferies Jon Block - Stifel Navin Tsai - BNP Paribas Operator Good day and welcome to the Beauty Health Company Fourth Quarter and 2024 Full Year Earnings and Conference Call. [Operator Instructions] Please note this event is being recorded.
Beauty Health (SKIN) International Revenue Performance Explored
Examine Beauty Health's (SKIN) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
The Beauty Health Company (SKIN) Q3 2024 Earnings Call Transcript
The Beauty Health Company (NASDAQ:SKIN ) Q3 2024 Results Conference Call November 12, 2024 4:30 PM ET Company Participants Norberto Aja - Investor Relations Marla Beck - President and CEO Mike Monahan - CFO Conference Call Participants Oliver Chen - TD Cowen Ashley Helgans - Jefferies Allen Gong - JPMorgan Susan Anderson - Canaccord Genuity Bruce Jackson - Benchmark Company Jon Block - Stifel Linda Bolton Weiser - DA Davidson Korinne Wolfmeyer - Piper Sandler Olivia Tong - Raymond James Operator Good day, and welcome to The Beauty Health 2024 Third Quarter Earnings Conference Call. All participants will be in listen only mode.
The Beauty Health Company (SKIN) Reports Q3 Loss, Tops Revenue Estimates
The Beauty Health Company (SKIN) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to earnings of $0.05 per share a year ago.
The Beauty Health Company Q2 2024 Earnings: Will It Ever Be Profitable?
At Moats and Monopolies, we focus on long only, high quality businesses but sometimes we like a little asymmetric risk/reward opportunity. The Beauty Health Company has been incredibly volatile over the past couple of years as investors have grown weary that the company may never be profitable. The company still isn't profitable, causing a sell off after earnings after a $17 million write off for replacing flagship models with technical issues combined with declining revenues.
